I am a
Home I AM A Search Login

Papers of the Week


Papers: 4 Jan 2020 - 10 Jan 2020


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 01


Headache


60


1

Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.

Authors

Ailani J, Lipton RB, Hutchinson S, Knievel K, Lu K, Butler M, Yu S Y, Finnegan M, Severt L, Trugman JM
Headache. 2020 01; 60(1):141-152.
PMID: 31913519.

Abstract

To evaluate the long-term safety and tolerability of ubrogepant for the acute treatment of migraine.